調査レポート | • レポートコード：QYR2104Z5672 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、TNF阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・TNF阻害剤の市場動向 ・企業の競争状況、市場シェア ・TNF阻害剤の種類別市場規模（単剤療法、併用療法） ・TNF阻害剤の用途別市場規模（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他） ・TNF阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・TNF阻害剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・TNF阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・TNF阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・TNF阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis、Boehringer Ingelheim、Amgen、BioPharma、Mochida Pharmaceutical、Hanall） ・結論 |
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF levels remain steady. However, in a patient with rheumatoid arthritis, the level of TNF is increasing which leads to more inflammation. TNF inhibitor drugs act as blockers for TNF substances. TNF alpha blockers are highly effective in the treatment of patients with active rheumatoid arthritis. These drugs are used in patients as a conventional second-line treatments.
The adalimumab segment is likely to expand at a significant pace during the forecast period. The drug is effectively used in a broad range of pain management therapies and is widely available over the counter. Based on distribution channel, the TNF inhibitors market can be segmented into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is likely to expand at a significant pace between 2017 and 2025, this is because patients with rheumatoid arthritis, arthritis give more preference to the hospitals for treatment. Increase in elderly population and rise in the prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the factors that drive the TNF inhibitors market. According to the National Health Interview Survey, in 2016, almost 20% of the global population was reported to be suffering from chronic pain, with rheumatoid arthritis being one of the major reasons. Moreover, according to the Center for Disease Control and Prevention, by 2040, approximately 78 million (26%) of the U.S. adults are projected to have arthritis. Owing to this, the consumption of TNF inhibitor dugs is likely to increase rapidly in the near future. However, side-effects associated with the use of TNF inhibitor drugs such as skin irritation, flushing, headache, and abdominal pain are estimated to hinder the market in the next few years.
Market Analysis and Insights: Global TNF Inhibitors Market
The global TNF Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global TNF Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global TNF Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global TNF Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global TNF Inhibitors market.
Global TNF Inhibitors Scope and Market Size
TNF Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TNF Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Skin Disease
Ankylosing Spondylitis
Gastrointestinal Disease
Rheumatoid Arthritis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Novartis
Boehringer Ingelheim
Amgen
BioPharma
Mochida Pharmaceutical
Hanall
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TNF Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global TNF Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Skin Disease
1.3.3 Ankylosing Spondylitis
1.3.4 Gastrointestinal Disease
1.3.5 Rheumatoid Arthritis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global TNF Inhibitors Market Perspective (2016-2027)
2.2 TNF Inhibitors Growth Trends by Regions
2.2.1 TNF Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 TNF Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 TNF Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 TNF Inhibitors Industry Dynamic
2.3.1 TNF Inhibitors Market Trends
2.3.2 TNF Inhibitors Market Drivers
2.3.3 TNF Inhibitors Market Challenges
2.3.4 TNF Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TNF Inhibitors Players by Revenue
3.1.1 Global Top TNF Inhibitors Players by Revenue (2016-2021)
3.1.2 Global TNF Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global TNF Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by TNF Inhibitors Revenue
3.4 Global TNF Inhibitors Market Concentration Ratio
3.4.1 Global TNF Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TNF Inhibitors Revenue in 2020
3.5 TNF Inhibitors Key Players Head office and Area Served
3.6 Key Players TNF Inhibitors Product Solution and Service
3.7 Date of Enter into TNF Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 TNF Inhibitors Breakdown Data by Type
4.1 Global TNF Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global TNF Inhibitors Forecasted Market Size by Type (2022-2027)
5 TNF Inhibitors Breakdown Data by Application
5.1 Global TNF Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global TNF Inhibitors Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America TNF Inhibitors Market Size (2016-2027)
6.2 North America TNF Inhibitors Market Size by Type
6.2.1 North America TNF Inhibitors Market Size by Type (2016-2021)
6.2.2 North America TNF Inhibitors Market Size by Type (2022-2027)
6.2.3 North America TNF Inhibitors Market Size by Type (2016-2027)
6.3 North America TNF Inhibitors Market Size by Application
6.3.1 North America TNF Inhibitors Market Size by Application (2016-2021)
6.3.2 North America TNF Inhibitors Market Size by Application (2022-2027)
6.3.3 North America TNF Inhibitors Market Size by Application (2016-2027)
6.4 North America TNF Inhibitors Market Size by Country
6.4.1 North America TNF Inhibitors Market Size by Country (2016-2021)
6.4.2 North America TNF Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe TNF Inhibitors Market Size (2016-2027)
7.2 Europe TNF Inhibitors Market Size by Type
7.2.1 Europe TNF Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe TNF Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe TNF Inhibitors Market Size by Type (2016-2027)
7.3 Europe TNF Inhibitors Market Size by Application
7.3.1 Europe TNF Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe TNF Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe TNF Inhibitors Market Size by Application (2016-2027)
7.4 Europe TNF Inhibitors Market Size by Country
7.4.1 Europe TNF Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe TNF Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific TNF Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific TNF Inhibitors Market Size by Type
8.2.1 Asia-Pacific TNF Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific TNF Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific TNF Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific TNF Inhibitors Market Size by Application
8.3.1 Asia-Pacific TNF Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific TNF Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific TNF Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific TNF Inhibitors Market Size by Region
8.4.1 Asia-Pacific TNF Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific TNF Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America TNF Inhibitors Market Size (2016-2027)
9.2 Latin America TNF Inhibitors Market Size by Type
9.2.1 Latin America TNF Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America TNF Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America TNF Inhibitors Market Size by Type (2016-2027)
9.3 Latin America TNF Inhibitors Market Size by Application
9.3.1 Latin America TNF Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America TNF Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America TNF Inhibitors Market Size by Application (2016-2027)
9.4 Latin America TNF Inhibitors Market Size by Country
9.4.1 Latin America TNF Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America TNF Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TNF Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa TNF Inhibitors Market Size by Type
10.2.1 Middle East & Africa TNF Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa TNF Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa TNF Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa TNF Inhibitors Market Size by Application
10.3.1 Middle East & Africa TNF Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa TNF Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa TNF Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa TNF Inhibitors Market Size by Country
10.4.1 Middle East & Africa TNF Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa TNF Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer TNF Inhibitors Introduction
11.1.4 Pfizer Revenue in TNF Inhibitors Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis TNF Inhibitors Introduction
11.2.4 Novartis Revenue in TNF Inhibitors Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim TNF Inhibitors Introduction
11.3.4 Boehringer Ingelheim Revenue in TNF Inhibitors Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen TNF Inhibitors Introduction
11.4.4 Amgen Revenue in TNF Inhibitors Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 BioPharma
11.5.1 BioPharma Company Details
11.5.2 BioPharma Business Overview
11.5.3 BioPharma TNF Inhibitors Introduction
11.5.4 BioPharma Revenue in TNF Inhibitors Business (2016-2021)
11.5.5 BioPharma Recent Development
11.6 Mochida Pharmaceutical
11.6.1 Mochida Pharmaceutical Company Details
11.6.2 Mochida Pharmaceutical Business Overview
11.6.3 Mochida Pharmaceutical TNF Inhibitors Introduction
11.6.4 Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2016-2021)
11.6.5 Mochida Pharmaceutical Recent Development
11.7 Hanall
11.7.1 Hanall Company Details
11.7.2 Hanall Business Overview
11.7.3 Hanall TNF Inhibitors Introduction
11.7.4 Hanall Revenue in TNF Inhibitors Business (2016-2021)
11.7.5 Hanall Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global TNF Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global TNF Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global TNF Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global TNF Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global TNF Inhibitors Market Share by Regions (2016-2021)
Table 8. Global TNF Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global TNF Inhibitors Market Share by Regions (2022-2027)
Table 10. TNF Inhibitors Market Trends
Table 11. TNF Inhibitors Market Drivers
Table 12. TNF Inhibitors Market Challenges
Table 13. TNF Inhibitors Market Restraints
Table 14. Global TNF Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global TNF Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top TNF Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TNF Inhibitors as of 2020)
Table 17. Ranking of Global Top TNF Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by TNF Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TNF Inhibitors Product Solution and Service
Table 21. Date of Enter into TNF Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TNF Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global TNF Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global TNF Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global TNF Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global TNF Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global TNF Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global TNF Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global TNF Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America TNF Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America TNF Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America TNF Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America TNF Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America TNF Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America TNF Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe TNF Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe TNF Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe TNF Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe TNF Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe TNF Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe TNF Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific TNF Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific TNF Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific TNF Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific TNF Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific TNF Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific TNF Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America TNF Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America TNF Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America TNF Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America TNF Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America TNF Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America TNF Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa TNF Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa TNF Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa TNF Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa TNF Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa TNF Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa TNF Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer TNF Inhibitors Product
Table 64. Pfizer Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis TNF Inhibitors Product
Table 69. Novartis Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Boehringer Ingelheim Company Details
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim TNF Inhibitors Product
Table 74. Boehringer Ingelheim Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen TNF Inhibitors Product
Table 79. Amgen Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 80. Amgen Recent Development
Table 81. BioPharma Company Details
Table 82. BioPharma Business Overview
Table 83. BioPharma TNF Inhibitors Product
Table 84. BioPharma Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 85. BioPharma Recent Development
Table 86. Mochida Pharmaceutical Company Details
Table 87. Mochida Pharmaceutical Business Overview
Table 88. Mochida Pharmaceutical TNF Inhibitors Product
Table 89. Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 90. Mochida Pharmaceutical Recent Development
Table 91. Hanall Company Details
Table 92. Hanall Business Overview
Table 93. Hanall TNF Inhibitors Product
Table 94. Hanall Revenue in TNF Inhibitors Business (2016-2021) & (US$ Million)
Table 95. Hanall Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TNF Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global TNF Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Skin Disease Case Studies
Figure 6. Ankylosing Spondylitis Case Studies
Figure 7. Gastrointestinal Disease Case Studies
Figure 8. Rheumatoid Arthritis Case Studies
Figure 9. Others Case Studies
Figure 10. TNF Inhibitors Report Years Considered
Figure 11. Global TNF Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global TNF Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global TNF Inhibitors Market Share by Regions: 2020 VS 2027
Figure 14. Global TNF Inhibitors Market Share by Regions (2022-2027)
Figure 15. Global TNF Inhibitors Market Share by Players in 2020
Figure 16. Global Top TNF Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TNF Inhibitors as of 2020
Figure 17. The Top 10 and 5 Players Market Share by TNF Inhibitors Revenue in 2020
Figure 18. Global TNF Inhibitors Revenue Market Share by Type (2016-2021)
Figure 19. Global TNF Inhibitors Revenue Market Share by Type (2022-2027)
Figure 20. North America TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America TNF Inhibitors Market Share by Type (2016-2027)
Figure 22. North America TNF Inhibitors Market Share by Application (2016-2027)
Figure 23. North America TNF Inhibitors Market Share by Country (2016-2027)
Figure 24. United States TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe TNF Inhibitors Market Share by Type (2016-2027)
Figure 28. Europe TNF Inhibitors Market Share by Application (2016-2027)
Figure 29. Europe TNF Inhibitors Market Share by Country (2016-2027)
Figure 30. Germany TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific TNF Inhibitors Market Share by Type (2016-2027)
Figure 38. Asia-Pacific TNF Inhibitors Market Share by Application (2016-2027)
Figure 39. Asia-Pacific TNF Inhibitors Market Share by Region (2016-2027)
Figure 40. China TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America TNF Inhibitors Market Share by Type (2016-2027)
Figure 48. Latin America TNF Inhibitors Market Share by Application (2016-2027)
Figure 49. Latin America TNF Inhibitors Market Share by Country (2016-2027)
Figure 50. Mexico TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa TNF Inhibitors Market Share by Type (2016-2027)
Figure 54. Middle East & Africa TNF Inhibitors Market Share by Application (2016-2027)
Figure 55. Middle East & Africa TNF Inhibitors Market Share by Country (2016-2027)
Figure 56. Turkey TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE TNF Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 63. BioPharma Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 64. Mochida Pharmaceutical Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 65. Hanall Revenue Growth Rate in TNF Inhibitors Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の強直性脊椎炎治療市場規模・現状・予測（2021年-2027年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…- 世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilica…
- 世界の強直性脊椎炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…